Cladribine versus fingolimod, natalizumab and interferon beta for multiple sclerosis

T. Kalincik; V. Jokubaitis; T. Spelman; D. Horakova; E. Havrdova; M. Trojano; J. Lechner-Scott; A. Lugaresi; A. Prat; M. Girard; P. Duquette; P. Grammond; C. Solaro; F. Grand'Maison; R. Hupperts; J. Prevost; P. Sola; D. Ferraro; M. Terzi; E. Butler; M. Slee; A. Kermode; M. Fabis-Pedrini; P. McCombe; M. Barnett; C. Shaw; S. Hodgkinson; H. Butzkueven; MSBase Study Grp

Cladribine versus fingolimod, natalizumab and interferon beta for multiple sclerosis

T. Kalincik, V. Jokubaitis, T. Spelman, D. Horakova, E. Havrdova, M. Trojano, J. Lechner-Scott, A. Lugaresi, A. Prat, M. Girard, P. Duquette, P. Grammond, C. Solaro, F. Grand'Maison, R. Hupperts, J. Prevost, P. Sola, D. Ferraro, M. Terzi, E. ButlerM. Slee, A. Kermode, M. Fabis-Pedrini, P. McCombe, M. Barnett, C. Shaw, S. Hodgkinson, H. Butzkueven, MSBase Study Grp

Centre for Neuromuscular and Neurological Disorders (Perron Institute)

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

1 Citation (Web of Science)

Original language	English
Pages (from-to)	596-597
Number of pages	2
Journal	Multiple Sclerosis
Volume	23
Publication status	Published - Oct 2017
Event	7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) - Paris, France Duration: 25 Oct 2017 → 28 Oct 2017

Cite this

Kalincik, T., Jokubaitis, V., Spelman, T., Horakova, D., Havrdova, E., Trojano, M., Lechner-Scott, J., Lugaresi, A., Prat, A., Girard, M., Duquette, P., Grammond, P., Solaro, C., Grand'Maison, F., Hupperts, R., Prevost, J., Sola, P., Ferraro, D., Terzi, M., ... MSBase Study Grp (2017). Cladribine versus fingolimod, natalizumab and interferon beta for multiple sclerosis. Multiple Sclerosis, 23, 596-597.

@article{36505322ed9241398c237831a7fb9416,

title = "Cladribine versus fingolimod, natalizumab and interferon beta for multiple sclerosis",

author = "T. Kalincik and V. Jokubaitis and T. Spelman and D. Horakova and E. Havrdova and M. Trojano and J. Lechner-Scott and A. Lugaresi and A. Prat and M. Girard and P. Duquette and P. Grammond and C. Solaro and F. Grand'Maison and R. Hupperts and J. Prevost and P. Sola and D. Ferraro and M. Terzi and E. Butler and M. Slee and A. Kermode and M. Fabis-Pedrini and P. McCombe and M. Barnett and C. Shaw and S. Hodgkinson and H. Butzkueven and {MSBase Study Grp}",

year = "2017",

month = oct,

language = "English",

volume = "23",

pages = "596--597",

journal = "Multiple Sclerosis",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

note = "7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) ; Conference date: 25-10-2017 Through 28-10-2017",

}

Kalincik, T, Jokubaitis, V, Spelman, T, Horakova, D, Havrdova, E, Trojano, M, Lechner-Scott, J, Lugaresi, A, Prat, A, Girard, M, Duquette, P, Grammond, P, Solaro, C, Grand'Maison, F, Hupperts, R, Prevost, J, Sola, P, Ferraro, D, Terzi, M, Butler, E, Slee, M, Kermode, A, Fabis-Pedrini, M, McCombe, P, Barnett, M, Shaw, C, Hodgkinson, S, Butzkueven, H & MSBase Study Grp 2017, 'Cladribine versus fingolimod, natalizumab and interferon beta for multiple sclerosis', Multiple Sclerosis, vol. 23, pp. 596-597.

TY - JOUR

T1 - Cladribine versus fingolimod, natalizumab and interferon beta for multiple sclerosis

AU - Kalincik, T.

AU - Jokubaitis, V.

AU - Spelman, T.

AU - Horakova, D.

AU - Havrdova, E.

AU - Trojano, M.

AU - Lechner-Scott, J.

AU - Lugaresi, A.

AU - Prat, A.

AU - Girard, M.

AU - Duquette, P.

AU - Grammond, P.

AU - Solaro, C.

AU - Grand'Maison, F.

AU - Hupperts, R.

AU - Prevost, J.

AU - Sola, P.

AU - Ferraro, D.

AU - Terzi, M.

AU - Butler, E.

AU - Slee, M.

AU - Kermode, A.

AU - Fabis-Pedrini, M.

AU - McCombe, P.

AU - Barnett, M.

AU - Shaw, C.

AU - Hodgkinson, S.

AU - Butzkueven, H.

AU - MSBase Study Grp

PY - 2017/10

Y1 - 2017/10

M3 - Abstract/Meeting Abstract

SN - 1352-4585

VL - 23

SP - 596

EP - 597

JO - Multiple Sclerosis

JF - Multiple Sclerosis

T2 - 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS)

Y2 - 25 October 2017 through 28 October 2017

ER -